SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001326732-23-000038
Filing Date
2023-11-07
Accepted
2023-11-07 16:03:02
Documents
17
Period of Report
2023-11-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xncr-20231103.htm   iXBRL 8-K 33545
2 EX-10.1 xncr-20231103xexx101.htm EX-10.1 450935
3 EX-10.2 xncr-20231103xexx102.htm EX-10.2 367350
4 EX-99.1 xncr-20231103xexx991.htm EX-99.1 13030
9 xencora.jpg GRAPHIC 8036
  Complete submission text file 0001326732-23-000038.txt   1146619

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xncr-20231103.xsd EX-101.SCH 2152
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xncr-20231103_def.xml EX-101.DEF 14781
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xncr-20231103_lab.xml EX-101.LAB 28738
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xncr-20231103_pre.xml EX-101.PRE 15423
11 EXTRACTED XBRL INSTANCE DOCUMENT xncr-20231103_htm.xml XML 2728
Mailing Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107
Business Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

IRS No.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36182 | Film No.: 231383580
SIC: 2834 Pharmaceutical Preparations